SEARCH

Search Details

Suzuki Ryota

Hokkaido University Hospital Division of Child Maternal and Female medicineAssistant Professor

Researcher basic information

■ Degree
  • Doctor of Philosophy, Hokkaido University, Mar. 2025
■ URL
researchmap URLホームページURL■ Various IDs
Researcher number
  • 31018659
ORCID IDJ-Global ID■ Research Keywords and Fields
Research Field
  • Life Science, Embryonic medicine and pediatrics
  • Life Science, Nephrology

Career

■ Career
Career
  • Apr. 2026 - Present
    Hokkaido University, Department of Pediatrics, 助教, Japan
  • Apr. 2025 - Mar. 2026
    Hokkaido University, Pediatrics, 医員, Japan
  • Apr. 2021 - Mar. 2025
    Hokkaido University, Graduate School of Medicine, Studeny, Japan
  • Oct. 2020 - Mar. 2021
    Nikko Memorial Hospital, Pediatrics, Resident, Japan
  • Apr. 2020 - Sep. 2020
    Hakodate Central General Hospital, Pediatrics, Resident, Japan
  • Apr. 2018 - Mar. 2020
    Nikko Memorial Hospital, Pediatrics, Resident, Japan
  • Apr. 2017 - Mar. 2018
    Kushiro Red Cross Hospital, Pediatrics, Resident, Japan
  • Apr. 2016 - Mar. 2017
    KKR Sapporo Medical Center, Pediatrics, Resident, Japan
  • Apr. 2014 - Mar. 2016
    Megumino Hospital, Resident, Japan
  • Apr. 2008 - Mar. 2014
    University of Miyazaki, Faculty of Medicine School of Medicine, Student, Japan
Educational Background
  • Apr. 2021 - Mar. 2025, Hokkaido University, Graduate School of Medecine, Department of Pediatrics, Japan
  • Apr. 2008 - Mar. 2014, University of Miyazaki, Faculty of Medicine, School of Medicine, Japan

Research activity information

■ Awards
  • Jun. 2024, Japanese Society for Pediatric Nephrology, Morita Award
    Systematic Review of Clinical Characteristics and Genotype-Phenotype Correlation in LAMB2-Associated Disease
    Ryota Suzuki
■ Papers
  • Investigation of clinical and genetic characteristics of Alport syndrome using a national registry in Japan (JP-ALPS).
    Okuda Y; Mikami N; Hamada R; Hataya H; Tanaka K; Terano C; Fujita N; Miura K; Ishizuka K; Shirai Y; Kamei K; Ogura M; Okamoto T; Suzuki R; Shinozuka S; Shima Y; Oka M; Shimabukuro W; Tsukaguchi H; Inagaki T; Nishiyama K; Hashimoto T; Ito N; Yamamura T; Horinouchi T; Ishikura K; Nakanishi K; Nozu K
    Clinical and experimental nephrology, 19 Sep. 2025
    Scientific journal,

    Background

    Comprehensive epidemiological information regarding Alport syndrome, particularly from national cohorts, is limited.

    Methods

    Utilizing a national Alport syndrome cohort in Japan established in October 2022, we analyzed clinical characteristics according to genotype. Only baseline data collected retrospectively at enrollment were used. We present longitudinal trends in estimated glomerular filtration rate (eGFR) and urine protein-to-creatinine ratio.

    Results

    Of the 121 patients included, 105 (86.8%) underwent genetic testing and 82 (67.8%) had a kidney biopsy. Among those with genetic testing, 77 (73.3%) had X-linked Alport syndrome. Kidney function was normal at disease onset, with a median eGFR of 112.9 (interquartile range, 99.3-131.1) mL/min/1.73 m2. Although a steep decline during adolescence was observed in some male patients with X-linked Alport syndrome, eGFR decline was relatively slow during childhood and adolescence; the point estimate of eGFR at age 20 was 88.6 mL/min/1.73 m2. Six patients transitioned to end-stage kidney disease during the follow-up period. Eighty-one patients (66.9%) used renin-angiotensin system (RAS) inhibitors, and the rate of eGFR decline was slower after RAS inhibitor initiation. Notably, the median ages at onset and diagnosis were 3.0 and 5.1 years, respectively, because Japan's widespread urinalysis screening program for 3-year-old children enables initiation of early treatment.

    Conclusions

    In our cohort, which consisted mainly of patients who did not require kidney replacement therapy in childhood and adolescence, kidney function was preserved throughout this period except for some male patients with X-linked Alport syndrome. RAS inhibitor use may be associated with a reduced rate of eGFR decline.
  • 小児難治性ネフローゼ症候群に対するリツキシマブ定期反復投与後の長期成績
    横川 涼介; 山本 朝日; 鈴木 諒太; 高橋 俊行; 林 麻子; 佐藤 泰征; 岡本 孝之
    日本腎臓学会誌, 67, 4, 572, 572, (一社)日本腎臓学会, Jun. 2025
    Japanese
  • Genotype and X-chromosome inactivation are associated with disease severity in females with X-linked Alport syndrome
    Ryota Suzuki; Nana Sakakibara; Sae Murakami; Yuta Ichikawa; Hideaki Kitakado; Chika Ueda; Yu Tanaka; Eri Okada; Atsushi Kondo; Yuya Aoto; Shinya Ishiko; Shingo Ishimori; China Nagano; Tomohiko Yamamura; Tomoko Horinouchi; Takayuki Okamoto; Kandai Nozu
    Nephrology Dialysis Transplantation, 01 Apr. 2025
    Scientific journal
  • Comprehensive Splice Pattern Analysis for Previously Reported <i>OCRL</i> Splicing Variants and Their Phenotypic Contributions.
    Rossanti R; Okada E; Sakakibara N; Suzuki R; Inoki Y; Ichikawa Y; Tanaka Y; Kitakado H; Ueda C; Kondo A; Aoto Y; Nagano C; Horinouchi T; Yamamura T; Ishimori S; Nozu K
    Kidney international reports, 10, 5, 1509, 1517, 03 Mar. 2025, [International Magazine]
    English, Scientific journal,

    Introduction

    Two distinct phenotypes of Dent disease-2 and Lowe syndrome are caused by oculocerebrorenal syndrome of Lowe (OCRL) abnormality. Previous genetic studies demonstrated that truncating variants in exons 1 to 7 results in Dent disease-2 and in exons 8 to 24, result in Lowe syndrome. Recently, we successfully identified a functional OCRL isoform, whose altered initiation codons (Met187 and Met206) in exon 8 can affect the OCRL-truncating variant phenotypes. However, the association between OCRL splicing variants and phenotypes is poorly understood.

    Methods

    We performed a detailed splicing pattern analysis of previously reported 28 OCRL splicing variants obtained from the Human Gene Mutation Database. We assessed the variant consequences at the mRNA level using an in vitro splicing assay with a minigene system, and examined their compatibility with in silico algorithms and correlation with disease phenotypes.

    Results

    Aberrant splicing was confirmed in all 27 variants, except for 1, in which splicing could not be experimentally confirmed in the minigene system, and therefore could not be concluded with certainty. Splicing variants in OCRL exons 1 to 7 resulted in Dent disease-2, and in exons 9 to 24 resulted in Lowe syndrome. In 1 case, c.561-2 A > G in exon 8 demonstrated Dent disease-2.

    Conclusion

    This study provides significant data on the pathogenicity of OCRL splicing variants and genotype-phenotype correlations. In c.561-2 A > G, the latter altered initiation codon of the OCRL isoform (Met206) was preserved, potentially indicating the Dent disease-2 phenotype. This result supports our recent finding regarding the altered initiation codons in exon 8 of the OCRL isoform.
  • Evaluation of pathogenicity of WT1 intron variants by in vitro splicing analysis.
    Inoue S; Atsushi Kondo; Inoki Y; Ichikawa Y; Tanaka Y; Ueda C; Kitakado H; Suzuki R; Okada E; Sakakibara N; Horinouchi T; Nozu K
    Clinical and experimental nephrology, 14 Jun. 2024
    Scientific journal,

    Background

    Wilms tumor 1 (WT1; NM_024426) causes Denys-Drash syndrome, Frasier syndrome, or isolated focal segmental glomerulosclerosis. Several WT1 intron variants are pathogenic; however, the pathogenicity of some variants remains undefined. Whether a candidate variant detected in a patient is pathogenic is very important for determining the therapeutic options for the patient.

    Methods

    In this study, we evaluated the pathogenicity of WT1 gene intron variants with undetermined pathogenicity by comparing their splicing patterns with those of the wild-type using an in vitro splicing assay using minigenes. The three variants registered as likely disease-causing genes: Mut1 (c.1017-9 T > C(IVS5)), Mut2 (c.1355-28C > T(IVS8)), Mut3 (c.1447 + 1G > C(IVS9)), were included as subjects along the 34 splicing variants registered in the Human Gene Mutation Database (HGMD)®.

    Results

    The results showed no significant differences in splicing patterns between Mut1 or Mut2 and the wild-type; however, significant differences were observed in Mut3.

    Conclusion

    We concluded that Mut1 and Mut2 do not possess pathogenicity although they were registered as likely pathogenic, whereas Mut3 exhibits pathogenicity. Our results suggest that the pathogenicity of intronic variants detected in patients should be carefully evaluated.
  • Systematic Review of Clinical Characteristics and Genotype-Phenotype Correlation in LAMB2-Associated Disease.
    Suzuki R; Sakakibara N; Ichikawa Y; Kitakado H; Ueda C; Tanaka Y; Okada E; Kondo A; Ishiko S; Ishimori S; Nagano C; Yamamura T; Horinouchi T; Okamoto T; Nozu K
    Kidney international reports, 04 Jul. 2023
    Scientific journal,

    Introduction

    Laminin subunit beta-2 (LAMB2)-associated disease, termed Pierson syndrome, presents with congenital nephrotic syndrome, ocular symptoms, and neuromuscular symptoms. In recent years, however, the widespread use of next-generation sequencing (NGS) has helped to discover a variety of phenotypes associated with this disease. Therefore, we conducted this systematic review.

    Methods

    A literature search of patients with LAMB2 variants was conducted, and 110 patients were investigated, including 12 of our patients. For genotype-phenotype correlation analyses, the extracted data were investigated for pathogenic variant types, the severity of nephropathy, and extrarenal symptoms. Survival analyses were also performed for the onset age of end-stage kidney disease (ESKD).

    Results

    Among all patients, 81 (78%) presented with congenital nephrotic syndrome, and 52 (55%) developed ESKD within 12 months. The median age at ESKD onset was 6.0 months. Kidney survival analysis showed that patients with biallelic truncating variants had a significantly earlier progression to ESKD than those with other variants (median age 1.2 months vs. 60.0 months, P < 0.05). Although the laminin N-terminal domain is functionally important in laminin proteins, and variants in the laminin N-terminal domain are said to result in a severe kidney phenotype such as earlier onset age and worse prognosis, there were no significant differences in onset age of nephropathy and progression to ESKD between patients with nontruncating variants located in the laminin N-terminal domain and those with variants located outside this domain.

    Conclusion

    This study revealed a diversity of LAMB2-associated diseases, characteristics of LAMB2 nephropathy, and genotype-phenotype correlations.
  • Association of Familial Fanconi Syndrome with a Novel GATM Variant.
    Kudo H; Suzuki R; Kondo A; Nozu K; Nakamura Y; Mikami H; Soma J; Nakaya I
    The Tohoku journal of experimental medicine, 08 Jun. 2023
    Scientific journal
  • All reported non-canonical splice site variants in GLA cause aberrant splicing.
    Eri Okada; Horinouchi T; Yamamura T; Aoto Y; Suzuki R; Ichikawa Y; Tanaka Y; Masuda C; Kitakado H; Kondo A; Sakakibara N; Ishiko S; Nagano C; Ishimori S; Usui J; Yamagata K; Matsuo M; Nozu K
    Clinical and experimental nephrology, 31 May 2023
    Scientific journal,

    Background

    Fabry disease is an X-linked lysosomal storage disorder caused by insufficient α-galactosidase A (GLA) activity resulting from variants in the GLA gene, which leads to glycosphingolipid accumulation and life-threatening, multi-organ complications. Approximately 50 variants have been reported that cause splicing abnormalities in GLA. Most were found within canonical splice sites, which are highly conserved GT and AG splice acceptor and donor dinucleotides, whereas one-third were located outside canonical splice sites, making it difficult to interpret their pathogenicity. In this study, we aimed to investigate the genetic pathogenicity of variants located in non-canonical splice sites within the GLA gene.

    Methods

    13 variants, including four deep intronic variants, were selected from the Human Gene Variant Database Professional. We performed an in vitro splicing assay to identify splicing abnormalities in the variants.

    Results

    All candidate non-canonical splice site variants in GLA caused aberrant splicing. Additionally, all but one variant was protein-truncating. The four deep intronic variants generated abnormal transcripts, including a cryptic exon, as well as normal transcripts, with the proportion of each differing in a cell-specific manner.

    Conclusions

    Validation of splicing effects using an in vitro splicing assay is useful for confirming pathogenicity and determining associations with clinical phenotypes.
  • Changes in bone turnover markers after discontinuing long-term glucocorticoid administration in children with idiopathic nephrotic syndrome: a multicenter retrospective observational study.
    Yasuhiro Ueda; Takayuki Okamoto; Yasuyuki Sato; Asako Hayashi; Toshiyuki Takahashi; Ryota Suzuki; Aoyagi H; MICHIHIKO UENO; Kobayashi N; Uetake K; Nakanishi M; Ariga T; Atsushi Manabe
    Pediatric nephrology (Berlin, Germany), 13 Apr. 2023
    Scientific journal,

    Background

    Glucocorticoids affect bone turnover. Little is known about how bone turnover changes when glucocorticoids are discontinued following long-term administration.

    Methods

    This retrospective observational study was conducted on the relationship between discontinuation of long-term administration of glucocorticoid and bone turnover markers (BTMs) in patients with childhood-onset idiopathic nephrotic syndrome. Serum bone alkaline phosphatase (BAP), intact procollagen type 1 N-terminal propeptide (P1NP), and tartrate-resistant acid phosphatase-5b (TRACP-5b) were evaluated as BTMs.

    Results

    Thirty-eight pairs of BTMs at glucocorticoid administration and after discontinuation were analyzed in 29 patients. The median age at baseline was 12.4 (interquartile range, 9.0-14.5) years, and the median time from the onset of nephrotic syndrome was 5.9 (3.3-9.7) years. The mean period from prednisolone discontinuation to the measurement of BTMs after glucocorticoid discontinuation was 3.5 ± 1.0 months. Changes in BTMs after glucocorticoid discontinuation were modest when the daily prednisolone dose was < 0.25 mg/kg/day (ln BAP standard deviation [SD] score, p = 0.19; log intact P1NP SD score, p = 0.70; TRACP-5b, p = 0.95). When the daily prednisolone dose was ≥ 0.25 mg/kg/day, all BTMs increased significantly after glucocorticoid discontinuation (ln BAP SD score, p < 0.01; log intact P1NP SD score, p < 0.01; TRACP-5b, p < 0.01).

    Conclusions

    Decreased BTMs can rise within a few months of discontinuing long-term glucocorticoid administration. When the administered glucocorticoid dose is low, changes in BTMs may be small. A higher resolution version of the Graphical abstract is available as Supplementary information.
  • Aberrant splicing caused by exonic single nucleotide variants positioned 2nd or 3rd to the last nucleotide in the COL4A5 gene.
    Eri Okada; Aoto Y; Horinouchi T; Yamamura T; Ichikawa Y; Tanaka Y; Ueda C; Kitakado H; Kondo A; Sakakibara N; Suzuki R; Usui J; Yamagata K; Iijima K; Nozu K
    Clinical and experimental nephrology, 12 Nov. 2022
    Scientific journal,

    Background and objectives

    The evident genotype-phenotype correlation shown by the X-linked Alport syndrome warrants the assessment of the impact of identified gene variants on aberrant splicing. We previously reported that single nucleotide variants (SNVs) in the last nucleotide of exons in COL4A5 cause aberrant splicing. It is known that the nucleotides located 2nd and 3rd to the last nucleotides of exons can also play an essential role in the first step of the splicing process. In this study, we aimed to investigate whether SNVs positioned 2nd or 3rd to the last nucleotide of exons in COL4A5 resulted in aberrant splicing.

    Methods

    We selected eight candidate variants: six from the Human Gene Variant Database Professional and two from our cohort. We performed an in-vitro splicing assay and reverse transcription-polymerase chain reaction (RT-PCR) for messenger RNA obtained from patients, if available.

    Results

    The candidate variants were initially classified into the following groups: three nonsense, two missense, and three synonymous variants. Splicing assays and RT-PCR for messenger RNA revealed that six of the eight variants caused aberrant splicing. Four variants, initially classified as non-truncating variants, were found to be truncating ones, which usually show relatively more severe phenotypes.

    Conclusion

    We revealed that exonic SNVs positioned 2nd or 3rd to the last nucleotide of exons in the COL4A5 were responsible for aberrant splicing. The results of our study suggest that attention should be paid when interpreting the pathogenicity of exonic SNVs near the 5' splice site.
  • CD44 as a pathological marker for the early detection of calcineurin inhibitor-induced nephrotoxicity post kidney transplantation.
    Hayashi A; Takayuki Okamoto; Nio-Kobayashi J; Iwahara N; Suzuki R; Ueda Y; Takahashi T; Yasuyuki Sato; Iwanaga T; Hotta K
    Biomedical research (Tokyo, Japan), 01 Oct. 2022
    Scientific journal, Long-term calcineurin inhibitor (CNI) administration causes irreversible nephrotoxicity. Therefore, early CNI-induced nephrotoxicity detection is necessary for patients who will need long-term CNI administration. There is no pathological indicator for early CNI-induced nephrotoxicity. Here, serial protocol kidney biopsy specimens from five kidney-transplant patients with severe CNI-induced nephrotoxicity were examined. We observed that the increase in CD44 expression in glomerular parietal epithelial cells (PECs) preceded the chronic pathological changes of CNI-induced nephrotoxicity such as tubular atrophy/interstitial fibrosis, arterial hyaline thickening, and focal segmental glomerulosclerosis (FSGS). This result suggests that CD44-positive PECs have pivotal roles in FSGS development in human CNI-induced nephrotoxicity as well as rodent models. CD44 could be useful as a pathological marker for early CNI-induced nephrotoxicity detection post kidney transplantation.
  • Cooccurrence of Alport syndrome and poststreptococcal acute glomerulonephritis with improvement after steroid administration
    Ryota Suzuki; Asako Hayashi; Megumi Endo; Yasuhiro Ueda; Toshiyuki Takahashi; Yasuyuki Sato; Takayuki Okamoto
    CEN Case Reports, 10 Apr. 2022
    Scientific journal
  • Outbreak of aseptic meningitis caused by echovirus 30 in Kushiro, Japan in 2017.
    Ryota Suzuki
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 06 May 2019
    Scientific journal,

    Background

    Echovirus 30 (E30) is one of the most common causative agents for aseptic meningitis.

    Objectives

    In the autumn of 2017, there was an outbreak caused by E30 in Kushiro, Hokkaido, Japan. The aim of this study was to characterize this outbreak.

    Study design

    Fifty-nine patients were admitted to the Department of Pediatrics, Kushiro Red Cross Hospital (KRCH) with clinical diagnosis of aseptic meningitis. Among those, 36 patients were finally diagnosed as E30-associated aseptic meningitis by the detection of viral RNA using reverse transcription-polymerase chain reaction (RT-PCR) and/or the evidence of more than four-fold rise in neutralizing antibody (NA) titers in the convalescent phase relative to those in the acute phase. We investigated these 36 confirmed cases.

    Results

    The median age was 6 years (range: 6 months-14 years). The positive signs and symptoms were as follows: fever (100%), headache (94%), vomiting (92%), jolt accentuation (77%), neck stiffness (74%), Kernig sign (29%), and abdominal pain (28%). The median cerebrospinal fluid (CSF) white cell count, neutrophil count, and lymphocyte count were 222/μL (range: 3-1434/μL), 144/μL (range: 1-1269/μL), and 85/μL (range: 2-354/μL), respectively. Although the detected viral genes demonstrated same cluster, they were different from E30 strains observed in Japan between 2010 and 2014.

    Conclusion

    We mainly showed clinical and virological features of the E30-associated aseptic meningitis outbreak that occurred in Kushiro. To prevent further spread of E30 infection, continuous surveillance of enterovirus (EV) circulation and standard precautions are considered essential.
■ Other Activities and Achievements
■ Books and other publications
■ Affiliated academic society
  • Present
    Japan Pediatric Society
  • Present
    Japanese Society of Nephrology
  • Present
    Japanese Society for Pediatric Nephrology